Home・Aandelen Lijst・Anika Therapeutics Inc

Anika Therapeutics Inc

Gesloten

SectorGezondheidszorg

21.15 2.57

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

20.39

Max

21.31

Belangrijke statistieken
By Trading Economics
Inkomsten	8.4M 3.3M
Verkoop	3M 33M
EPS	0.3
Winstmarge	10.147
Werknemers	235
EBITDA	8.3M 4.9M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+0.67% upside

Dividenden
By Acuity
Volgende Winsten	4 nov 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	80M 278M
Vorige openingsprijs	18.58
Vorige sluitingsprijs	21.15

Nieuwssentiment

By Acuity

50%

112 / 339 Rangschikking in Healthcare

Anika Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

14 sep 2026, 19:16 UTC

Anika Therapeutics shares are advancing despite broader market volatility and renewed inflation concerns. No specific news was identified to explain today's price movement.

11 sep 2026, 22:41 UTC

Anika Therapeutics Inc shares are lower in after-market hours, declining from earlier returns. The stock remains below its 20-day moving average and near recent lows.

10 sep 2026, 20:07 UTC

Anika Therapeutics Inc. is higher today, with no specific news identified. The broader market remains flat amid recent interest rate hikes from the European Central Bank.

9 sep 2026, 20:07 UTC

Anika Therapeutics Inc's shares are lower today, with no specific news identified. The stock remains below its 20-day moving average.

8 sep 2026, 20:07 UTC

Anika Therapeutics shares are higher amid a broader market recovery, despite no specific company news driving the price movement.

3 sep 2026, 20:07 UTC

Anika Therapeutics Inc shares declined during Thursday's session, reflecting ongoing selling pressure amid broader market dynamics and rising jobless claims.

2 sep 2026, 20:08 UTC

Anika Therapeutics Inc shares are higher today, reflecting positive momentum despite no specific company news. The stock remains above its 20-day moving average.

1 sep 2026, 19:11 UTC

Anika Therapeutics Inc is gaining today, despite earlier session pullbacks. Broader market movements reflect rising bond yields amid expectations for monetary tightening.

31 aug 2026, 22:16 UTC

Anika Therapeutics Inc shares are lower in after-market trading amid broader market concerns over inflation and potential interest rate hikes. No specific company news was identified.

28 aug 2026, 21:01 UTC

Anika Therapeutics Inc shares are higher in after-market hours, trading above the 20-day moving average and near the upper end of their one-month range.

27 aug 2026, 21:01 UTC

Anika Therapeutics Inc shares are lower in after-market hours with no specific news identified for the decline. The stock has gained significantly over the past month.

26 aug 2026, 21:51 UTC

Anika Therapeutics Inc shares are higher in after-market trading, continuing positive momentum after three consecutive sessions of gains, despite no specific company news.

25 aug 2026, 21:01 UTC

Anika Therapeutics Inc shares are lower in after-market trading, with no specific news identified for the decline. The stock remains above its 20-day moving average.

24 aug 2026, 19:56 UTC

Anika Therapeutics Inc. shares are lower today amid broader market pressures, despite strong performance over the past month and trading above its 20-day moving average.

21 aug 2026, 21:01 UTC

Anika Therapeutics Inc is trading higher in after-market hours, showing unusual strength. No specific news was identified to explain this price movement.

20 aug 2026, 21:01 UTC

Anika Therapeutics shares are trading higher in after-market hours, showing steady gains since Thursday's close and remaining above the 20-day moving average.

19 aug 2026, 22:01 UTC

Anika Therapeutics Inc shares are lower in after-market trading. No specific news was identified to explain the decline following Wednesday's close.

18 aug 2026, 20:06 UTC

Anika Therapeutics Inc's shares are higher during Tuesday's session, reflecting overall positive market performance, despite pulling back slightly from an earlier peak.

17 aug 2026, 20:06 UTC

Anika Therapeutics Inc shares are lower amid broader market declines, reflecting significant downward pressure following disappointing U.S. retail sales data for July.

14 aug 2026, 22:01 UTC

Anika Therapeutics Inc is trading higher in after-market hours, reflecting stability near the upper end of its one-month range and above its 20-day moving average.

13 aug 2026, 20:01 UTC

Anika Therapeutics Inc shares declined during Thursday's session, continuing a downward trend since Wednesday's close. No specific news was identified to explain the movement.

12 aug 2026, 19:51 UTC

Anika Therapeutics Inc is higher today, supported by positive sentiment from a recent inflation report, despite no specific company news identified.

11 aug 2026, 20:02 UTC

Anika Therapeutics Inc is trading higher, showing notable gains and peaking after an early dip, with no specific news identified to explain the movement.

10 aug 2026, 20:01 UTC

Anika Therapeutics shares declined during Monday's session, hitting a low of -3.68%, amid cautious investor sentiment following recent labor market data.

7 aug 2026, 20:03 UTC

Anika Therapeutics Inc shares are higher today, continuing a strong upward trend since Thursday's close amid broader market gains. No specific news was identified.

6 aug 2026, 20:02 UTC

Anika Therapeutics Inc. is trading higher Thursday, reflecting strong momentum despite a pullback from session highs. Broader economic data may influence investor sentiment.

5 aug 2026, 21:01 UTC

Anika Therapeutics Inc shares are higher in after-market hours, maintaining a gain above the 20-day moving average and near the upper end of the one-month range.

4 aug 2026, 19:51 UTC

Anika Therapeutics Inc. shares are lower today amid unusual volatility, despite a broader market reaction to declining crude oil prices.

3 aug 2026, 19:51 UTC

Anika Therapeutics Inc is sharply higher today, with no specific company news identified. Broader market dynamics, including falling oil prices, may be influencing performance.

31 jul 2026, 23:06 UTC

Anika Therapeutics Inc shares are higher in after-market trading, reflecting notable volatility earlier in the session and strong recent performance above the 20-day moving average.

Peer Vergelijking

Prijswijziging

Anika Therapeutics Inc Prognose

Koersdoel

By TipRanks

0.67% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 21 USD 0.67%

Hoogste 21 USD

Laagste 21 USD

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Anika Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

2 ratings

Buy

Hold

Sell

Gebaseerd op 2 analisten die aandelenratings hebben gegeven aan Anika Therapeutics Inc - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

112 / 339 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Anika Therapeutics Inc

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products includes Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide both short- and long-term pain relief. The company's joint preservation and restoration product family comprises and orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions used to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants, which are designed to treat upper and lower extremity orthopedic conditions. In addition, it offers non-orthopedic products comprising HA-based products for non-orthopedic applications including Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and Hyalomatrix used for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.